S-Nitrosylation of parkin as a novel regulator of p53-mediated neuronal cell death in sporadic Parkinson’s disease

S-Nitrosylation of parkin as a novel regulator of p53-mediated neuronal cell death in sporadic Parkinson’s disease

Bibliographic Details
Main Authors:	Sunico, Carmen R, Nakamura, Tomohiro, Rockenstein, Edward, Mante, Michael, Adame, Anthony, Chan, Shing Fai, Newmeyer, Traci Fang, Masliah, Eliezer, Nakanishi, Nobuki, Lipton, Stuart A
Format:	Online
Language:	English
Published:	BioMed Central 2013
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765907/

Similar Items

Lenalidomide reduces microglial activation and behavioral deficits in a transgenic model of Parkinson’s disease
by: Valera, Elvira, et al.
Published: (2015)

Redox Regulation of Protein Function via Cysteine S-Nitrosylation and Its Relevance to Neurodegenerative Diseases
by: Akhtar, Mohd Waseem, et al.
Published: (2012)

S-nitrosylation regulates mitochondrial quality control via activation of parkin
by: Ozawa, Kentaro, et al.
Published: (2013)

TOM40 Mediates Mitochondrial Dysfunction Induced by α-Synuclein Accumulation in Parkinson’s Disease
by: Bender, Andreas, et al.
Published: (2013)

Neuropeptide Treatment with Cerebrolysin Enhances the Survival of Grafted Neural Stem Cell in an α-Synuclein Transgenic Model of Parkinson’s Disease
by: Rockenstein, Edward, et al.
Published: (2016)

Longitudinal live imaging of retinal α-synuclein::GFP deposits in a transgenic mouse model of Parkinson’s Disease/Dementia with Lewy Bodies
by: Price, Diana L., et al.
Published: (2016)

Combined exposure to Maneb and Paraquat alters transcriptional regulation of neurogenesis-related genes in mice models of Parkinson’s disease
by: Desplats, Paula, et al.
Published: (2012)

Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick’s disease and fronto-temporal tauopathies
by: Rockenstein, Edward, et al.
Published: (2015)

Brain-derived exosomes from dementia with Lewy bodies propagate α-synuclein pathology
by: Jennifer Ngolab, et al.
Published: (2017-06-01)

Regulation of the unfolded protein response via S-nitrosylation of sensors of endoplasmic reticulum stress
by: Nakato, Ryosuke, et al.
Published: (2015)

MEF2C Enhances Dopaminergic Neuron Differentiation of Human Embryonic Stem Cells in a Parkinsonian Rat Model
by: Cho, Eun-Gyung, et al.
Published: (2011)

Sporadic Parkinsonism
by: Nicoletti, G
Published: (2010)

A brain-targeted, modified neurosin (kallikrein-6) reduces α-synuclein accumulation in a mouse model of multiple system atrophy
by: Spencer, Brian, et al.
Published: (2015)

Mitophagy and Parkinson's disease: The PINK1–parkin link☆
by: Deas, Emma, et al.
Published: (2011)

Is PARKIN parkinsonism a cancer predisposition syndrome?
by: Schüle, Birgitt, et al.
Published: (2015)

Will Crystal Parkin Help in Understanding the Future of Parkinson’s Disease?
by: Olszewska, Diana Angelika, et al.
Published: (2015)

Modulation of aberrant CDK5 signaling rescues impaired neurogenesis in models of Alzheimer's disease
by: Crews, L, et al.
Published: (2011)

Hypoestoxide reduces neuroinflammation and α-synuclein accumulation in a mouse model of Parkinson’s disease
by: Kim, Changyoun, et al.
Published: (2015)

Oxidation of the cysteine-rich regions of parkin perturbs its E3 ligase activity and contributes to protein aggregation
by: Meng, Fanjun, et al.
Published: (2011)

Age-dependent molecular alterations in the autophagy pathway in HIVE patients and in a gp120 tg mouse model: reversal with beclin-1 gene transfer
by: Fields, Jerel, et al.
Published: (2013)

Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy
by: Mandler, Markus, et al.
Published: (2015)

Neuregulin 1 improves cognitive deficits and neuropathology in an Alzheimer’s disease model
by: Xu, Jiqing, et al.
Published: (2016)

α‐synuclein conformational antibodies fused to penetratin are effective in models of Lewy body disease
by: Spencer, Brian, et al.
Published: (2016)

A Novel Triple Repeat Mutant Tau Transgenic Model That Mimics Aspects of Pick’s Disease and Fronto-Temporal Tauopathies
by: Rockenstein, Edward, et al.
Published: (2015)

Cerebrolysin™ efficacy in a transgenic model of tauopathy: role in regulation of mitochondrial structure
by: Rockenstein, Edward, et al.
Published: (2014)

Neuroprotective effects of the immunomodulatory drug FK506 in a model of HIV1-gp120 neurotoxicity
by: Fields, Jerel A., et al.
Published: (2016)

Serum from Parkinson’s disease patients presents excess of protein halogenation and nitrosylation, with anomalous nitrosylation of serum α-synuclein as potentially etiological factor
by: Fernandez, Emilio, et al.
Published: (2013)

Metformin Restores Parkin-Mediated Mitophagy, Suppressed by Cytosolic p53
by: Song, Young Mi, et al.
Published: (2016)

Parkin’ control: regulation of PGC-1α through PARIS in Parkinson’s disease
by: Castillo-Quan, Jorge Iván
Published: (2011)

parkin counteracts symptoms in a Drosophila model of Parkinson's disease
by: Haywood, Annika FM, et al.
Published: (2004)

The Parkinson’s disease genes Fbxo7 and Parkin interact to mediate mitophagy
by: Burchell, Victoria S, et al.
Published: (2013)

A molecular explanation for the recessive nature of parkin-linked Parkinson’s disease
by: Spratt, Donald E., et al.
Published: (2013)

Parkinson’s disease-linked Parkin mutations impair glutamatergic signaling in hippocampal neurons
by: Mei Zhu, et al.
Published: (2018-09-01)

Parkin loss of function contributes to RTP801 elevation and neurodegeneration in Parkinson's disease
by: Romaní-Aumedes, J, et al.
Published: (2014)

New Perception of Mitochondrial Regulatory Pathway in Parkinsonism – Ubiquitin, PINK1, and Parkin
by: Olszewska, Diana Angelika, et al.
Published: (2014)

PINK1 and Parkin – mitochondrial interplay between phosphorylation and ubiquitylation in Parkinson's disease
by: Kazlauskaite, Agne, et al.
Published: (2015)

S-Nitrosylation of mitochondrial caspases
by: Mannick, Joan B., et al.
Published: (2001)

S-nitrosylation of Ras in breast cancer
by: Marshall, Harvey E, et al.
Published: (2012)

Reversible S-Nitrosylation in an Engineered Azurin
by: Tian, Shiliang, et al.
Published: (2016)

Elevated glucose and oligomeric β-amyloid disrupt synapses via a common pathway of aberrant protein S-nitrosylation
by: Akhtar, Mohd Waseem, et al.
Published: (2016)